Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$296.4m reported value +23.0% vs Q1 2023
81positions
54.1%in top 10
26 new 11 added 18 reduced 35 sold out vs Q1 2023

Options: 24 call positions ($174.4m notional), 17 put positions ($170.0m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ACELYRIN INC COM COM 2,918,426 $61.0m20.58% 20.58% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.9m
2 CHINOOK THERAPEUTICS INC COM ADRO ADRO 283,464 $13.0m4.40% 4.40% UnchangedShares held: Q3 2022 283.5k, Q4 2022 283.5k, Q1 2023 283.5k, Q2 2023 283.5k
3 APELLIS PHARMACEUTICALS INC COM APLS APLS 133,800 $12.2m4.11% 4.11% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k, Q2 2023 133.8k +33.8k +33,800 33.8%
4 MERCK & CO INC COM MRK MRK 100,000 $11.5m3.89% 3.89% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k, Q2 2023 100.0k
5 IDEAYA BIOSCIENCES INC COM IDYA IDYA 490,893 $11.5m3.89% 3.89% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 490.9k
6 NUVALENT INC COM COM 272,752 $11.5m3.88% 3.88% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 272.8k
7 DISC MEDICINE INC COM IRON IRON 240,031 $10.7m3.60% 3.60% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 240.0k
8 INSMED INC COM PAR $.01 INSM INSM 485,000 $10.2m3.45% 3.45% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 485.0k, Q2 2023 485.0k
9 BIOHAVEN LTD COM BHVN BHVN 427,417 $10.2m3.45% 3.45% AddedShares held: Q3 2022 0, Q4 2022 837.5k, Q1 2023 402.3k, Q2 2023 427.4k +25.1k +25,091 6.2%
10 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 475,000 $8.6m2.89% 2.89% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 475.0k
11 IMMUNOGEN INC COM IMGN IMGN 447,700 $8.4m2.85% 2.85% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 447.7k
12 BRIDGEBIO PHARMA INC COM BBIO BBIO 429,686 $7.4m2.49% 2.49% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 594.7k, Q2 2023 429.7k -165.0k -165,000 -27.8%
13 VAXCYTE INC COM PCVX PCVX 140,000 $7.0m2.36% 2.36% ReducedShares held: Q3 2022 0, Q4 2022 250.0k, Q1 2023 225.0k, Q2 2023 140.0k -85.0k -85,000 -37.8%
14 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 611,932 $6.6m2.24% 2.24% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 611.9k
15 BIOMEA FUSION INC COM BMEA BMEA 275,875 $6.1m2.04% 2.04% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 211.0k, Q2 2023 275.9k +64.9k +64,900 30.8%
16 ARCUS BIOSCIENCES INC COM RCUS RCUS 280,000 $5.7m1.92% 1.92% AddedShares held: Q3 2022 0, Q4 2022 138.0k, Q1 2023 230.0k, Q2 2023 280.0k +50.0k +50,000 21.7%
17 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 121,658 $5.6m1.89% 1.89% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 121.7k
18 XENON PHARMACEUTICALS INC COM XENE XENE 135,486 $5.2m1.76% 1.76% ReducedShares held: Q3 2022 160.5k, Q4 2022 160.5k, Q1 2023 160.5k, Q2 2023 135.5k -25.0k -25,000 -15.6%
19 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 203,037 $5.2m1.75% 1.75% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 207.1k, Q2 2023 203.0k -4.1k -4,075 -2.0%
20 ASTRIA THERAPEUTICS INC COM CATB CATB 579,390 $4.8m1.63% 1.63% ReducedShares held: Q3 2022 699.4k, Q4 2022 675.2k, Q1 2023 869.4k, Q2 2023 579.4k -290.0k -290,000 -33.4%
21 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 130,000 $4.6m1.56% 1.56% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 130.0k
22 LYRA THERAPEUTICS INC COM LYRA LYRA 978,626 $4.0m1.36% 1.36% AddedShares held: Q3 2022 343.7k, Q4 2022 343.7k, Q1 2023 343.7k, Q2 2023 978.6k +634.9k +634,941 184.8%
23 LONGBOARD PHARMACEUTICALS IN COM COM 504,253 $3.7m1.25% 1.25% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 504.3k
24 VOYAGER THERAPEUTICS INC COM VYGR VYGR 300,000 $3.4m1.16% 1.16% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.0k
25 ALLAKOS INC COM ALLKG ALLKG 772,092 $3.4m1.14% 1.14% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 772.1k
26 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 654,945 $3.2m1.06% 1.06% AddedShares held: Q3 2022 350.0k, Q4 2022 254.9k, Q1 2023 254.9k, Q2 2023 654.9k +400.0k +400,000 156.9%
27 TERNS PHARMACEUTICALS INC COM COM 315,480 $2.8m0.93% 0.93% ReducedShares held: Q3 2022 904.1k, Q4 2022 737.3k, Q1 2023 721.3k, Q2 2023 315.5k -405.9k -405,861 -56.3%
28 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 545,103 $2.8m0.93% 0.93% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 545.1k
29 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 174,510 $2.5m0.83% 0.83% UnchangedShares held: Q3 2022 492.3k, Q4 2022 367.1k, Q1 2023 174.5k, Q2 2023 174.5k
30 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 1,705,605 $2.4m0.80% 0.80% AddedShares held: Q3 2022 2.1m, Q4 2022 1.9m, Q1 2023 1.4m, Q2 2023 1.7m +350.0k +350,000 25.8%
31 ROIVANT SCIENCES LTD SHS ROIV ROIV 225,000 $2.3m0.77% 0.77% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 575.0k, Q2 2023 225.0k -350.0k -350,000 -60.9%
32 ACLARIS THERAPEUTICS INC COM ACRS ACRS 200,163 $2.1m0.70% 0.70% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 300.2k, Q2 2023 200.2k -100.0k -100,000 -33.3%
33 KEZAR LIFE SCIENCES INC COM COM 841,596 $2.1m0.70% 0.70% UnchangedShares held: Q3 2022 728.6k, Q4 2022 630.0k, Q1 2023 841.6k, Q2 2023 841.6k
34 BIOVIE INC CL A NEW CL A NEW 448,556 $1.9m0.65% 0.65% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 348.6k, Q2 2023 448.6k +100.0k +100,000 28.7%
35 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 160,200 $1.8m0.60% 0.60% AddedShares held: Q3 2022 85.2k, Q4 2022 85.2k, Q1 2023 85.2k, Q2 2023 160.2k +75.0k +75,000 88.0%
36 ELEVATION ONCOLOGY INC COM COM 1,149,490 $1.7m0.59% 0.59% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
37 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 25,000 $1.7m0.58% 0.58% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 25.0k
38 MERUS N V COM MRUS MRUS 63,125 $1.7m0.56% 0.56% ReducedShares held: Q3 2022 0, Q4 2022 156.0k, Q1 2023 208.7k, Q2 2023 63.1k -145.5k -145,525 -69.8%
39 IMMUNIC INC COM COM 650,000 $1.6m0.55% 0.55% UnchangedShares held: Q3 2022 0, Q4 2022 650.0k, Q1 2023 650.0k, Q2 2023 650.0k
40 JASPER THERAPEUTICS INC COM COM 1,125,087 $1.5m0.52% 0.52% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.1m, Q2 2023 1.1m -1.2k -1,200 -0.1%
41 SCPHARMACEUTICALS INC COM SCPH SCPH 150,000 $1.5m0.52% 0.52% NewShares held: Q3 2022 479.4k, Q4 2022 0, Q1 2023 0, Q2 2023 150.0k
42 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 192,260 $1.5m0.51% 0.51% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 192.3k, Q2 2023 192.3k
43 BLUEBIRD BIO INC COM COM 412,628 $1.4m0.46% 0.46% UnchangedShares held: Q3 2022 462.6k, Q4 2022 812.6k, Q1 2023 412.6k, Q2 2023 412.6k
44 MILESTONE PHARMACEUTICALS IN COM MIST MIST 460,416 $1.3m0.44% 0.44% UnchangedShares held: Q3 2022 855.6k, Q4 2022 460.4k, Q1 2023 460.4k, Q2 2023 460.4k
45 KALVISTA PHARMACEUTICALS INC COM KALV KALV 140,000 $1.3m0.43% 0.43% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 140.0k, Q2 2023 140.0k
46 RENEO PHARMACEUTICALS INC COM COM 155,819 $1.0m0.34% 0.34% UnchangedShares held: Q3 2022 155.8k, Q4 2022 155.8k, Q1 2023 155.8k, Q2 2023 155.8k
47 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 35,000 $966.7k0.33% 0.33% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 35.0k
48 ARDELYX INC COM ARDX ARDX 278,825 $945.2k0.32% 0.32% ReducedShares held: Q3 2022 3.2m, Q4 2022 1.4m, Q1 2023 578.8k, Q2 2023 278.8k -300.0k -300,000 -51.8%
49 TYRA BIOSCIENCES INC COM TYRA TYRA 48,170 $820.3k0.28% 0.28% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 48.2k, Q2 2023 48.2k
50 TRACON PHARMACEUTICALS INC COM NEW COM NEW 2,765,530 $804.8k0.27% 0.27% UnchangedShares held: Q3 2022 2.8m, Q4 2022 2.8m, Q1 2023 2.8m, Q2 2023 2.8m
51 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 472,625 $765.7k0.26% 0.26% UnchangedShares held: Q3 2022 0, Q4 2022 422.6k, Q1 2023 472.6k, Q2 2023 472.6k
52 STOKE THERAPEUTICS INC COM STOK STOK 70,390 $748.2k0.25% 0.25% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 70.4k
53 COGENT BIOSCIENCES INC COM COGT COGT 62,766 $743.1k0.25% 0.25% UnchangedShares held: Q3 2022 162.8k, Q4 2022 62.8k, Q1 2023 62.8k, Q2 2023 62.8k
54 KARYOPHARM THERAPEUTICS INC COM COM 400,000 $716.0k0.24% 0.24% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 300.0k, Q2 2023 400.0k +100.0k +100,000 33.3%
55 X4 PHARMACEUTICALS INC COM COM 349,133 $677.3k0.23% 0.23% UnchangedShares held: Q3 2022 568.6k, Q4 2022 349.1k, Q1 2023 349.1k, Q2 2023 349.1k
56 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 260,087 $619.0k0.21% 0.21% UnchangedShares held: Q3 2022 260.1k, Q4 2022 260.1k, Q1 2023 260.1k, Q2 2023 260.1k
57 FIBROGEN INC COM COM 228,420 $616.7k0.21% 0.21% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 228.4k
58 IMMATICS N.V SHS IMTX IMTX 49,031 $565.8k0.19% 0.19% ReducedShares held: Q3 2022 49.0k, Q4 2022 49.0k, Q1 2023 179.6k, Q2 2023 49.0k -130.5k -130,521 -72.7%
59 REATA PHARMACEUTICALS INC CL A RETA RETA 5,472 $557.9k0.19% 0.19% ReducedShares held: Q3 2022 4.1k, Q4 2022 0, Q1 2023 80.6k, Q2 2023 5.5k -75.1k -75,092 -93.2%
60 HOOKIPA PHARMA INC COM COM 600,000 $528.0k0.18% 0.18% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 600.0k
61 OCULAR THERAPEUTIX INC COM OCUL OCUL 100,000 $516.0k0.17% 0.17% ReducedShares held: Q3 2022 265.0k, Q4 2022 200.0k, Q1 2023 200.0k, Q2 2023 100.0k -100.0k -100,000 -50.0%
62 PROTARA THERAPEUTICS INC COM STK TARA TARA 188,664 $450.9k0.15% 0.15% UnchangedShares held: Q3 2022 188.7k, Q4 2022 188.7k, Q1 2023 188.7k, Q2 2023 188.7k
63 KODIAK SCIENCES INC COM KOD KOD 62,527 $431.4k0.15% 0.15% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 162.5k, Q2 2023 62.5k -100.0k -100,000 -61.5%
64 BRAINSTORM CELL THERAPEUTICS COM NEW COM NEW 189,935 $391.3k0.13% 0.13% UnchangedShares held: Q3 2022 189.9k, Q4 2022 189.9k, Q1 2023 189.9k, Q2 2023 189.9k
65 ANEBULO PHARMACEUTICALS INC COM ANEB ANEB 156,203 $340.5k0.11% 0.11% UnchangedShares held: Q3 2022 156.2k, Q4 2022 156.2k, Q1 2023 156.2k, Q2 2023 156.2k
66 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 221,830 $303.9k0.10% 0.10% UnchangedShares held: Q3 2022 221.8k, Q4 2022 221.8k, Q1 2023 221.8k, Q2 2023 221.8k
67 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 891,676 $300.2k0.10% 0.10% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 891.7k
68 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 213,392 $279.5k0.09% 0.09% ReducedShares held: Q3 2022 245.9k, Q4 2022 313.4k, Q1 2023 236.7k, Q2 2023 213.4k -23.3k -23,317 -9.8%
69 POINT BIOPHARMA GLOBAL INC COM COM 28,784 $260.8k0.09% 0.09% ReducedShares held: Q3 2022 450.4k, Q4 2022 139.6k, Q1 2023 139.6k, Q2 2023 28.8k -110.8k -110,781 -79.4%
70 CONNECT BIOPHARMA HLDGS LTD ADS ADS 219,501 $243.6k0.08% 0.08% UnchangedShares held: Q3 2022 219.5k, Q4 2022 219.5k, Q1 2023 219.5k, Q2 2023 219.5k
71 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 313,677 $219.2k0.07% 0.07% AddedShares held: Q3 2022 315.1k, Q4 2022 255.1k, Q1 2023 228.7k, Q2 2023 313.7k +85.0k +85,000 37.2%
72 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 2,090 $186.5k0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.1k
73 MERSANA THERAPEUTICS INC COM COM 50,000 $164.5k0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 50.0k
74 RELMADA THERAPEUTICS INC COM RLMD RLMD 65,491 $161.1k0.05% 0.05% UnchangedShares held: Q3 2022 0, Q4 2022 65.5k, Q1 2023 65.5k, Q2 2023 65.5k
75 SYNLOGIC INC COM COM 306,757 $131.9k0.04% 0.04% UnchangedShares held: Q3 2022 306.8k, Q4 2022 306.8k, Q1 2023 306.8k, Q2 2023 306.8k
76 AVROBIO INC COM COM 134,146 $127.5k0.04% 0.04% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 134.1k
77 FOGHORN THERAPEUTICS INC COM FHTX FHTX 15,000 $105.6k0.04% 0.04% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 15.0k
78 FINCH THERAPEUTICS GROUP INC COM NEW COM NEW 7,917 $67.5k0.02% 0.02% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 7.9k
79 ASLAN PHARMACEUTICALS LTD SPON ADS NEW SPON ADS NEW 164,088 $29.8k0.01% 0.01% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 164.1k, Q2 2023 164.1k
80 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 75 $17.3k0.01% 0.01% UnchangedShares held: Q3 2022 0, Q4 2022 75, Q1 2023 75, Q2 2023 75
81 ERYTECH PHARMA SPONSORED ADR SPONSORED ADR 3,019 $2.3k0.00% 0.00% ReducedShares held: Q3 2022 3.0k, Q4 2022 3.0k, Q1 2023 248.4k, Q2 2023 3.0k -245.4k -245,407 -98.8%

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
PROMETHEUS BIOSCIENCES INC 125,926 $13.5m125.9k shares
IMMUNOVANT INC IMVT IMVT 774,398 $12.0m774.4k shares
BELLUS HEALTH INC NEW BLU BLU 885,334 $6.4m885.3k shares
IVERIC BIO INC OPHT OPHT 213,521 $5.2m213.5k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 50,000 $4.9m50.0k shares
AEROVATE THERAPEUTICS INC 195,146 $3.9m195.1k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 106,057 $3.8m106.1k shares
SELECT SECTOR SPDR TR XLV XLV 27,469 $3.6m27.5k shares
ALTIMMUNE INC ALT ALT 677,300 $2.9m677.3k shares
BIOXCEL THERAPEUTICS INC 133,014 $2.5m133.0k shares
VENTYX BIOSCIENCES INC VTYX VTYX 65,000 $2.2m65.0k shares
CYTOKINETICS INC CYTK CYTK 55,666 $2.0m55.7k shares
AKERO THERAPEUTICS INC AKRO AKRO 50,000 $1.9m50.0k shares
MACROGENICS INC MGNX MGNX 250,000 $1.8m250.0k shares
MORPHIC HLDG INC MORF MORF 45,873 $1.7m45.9k shares
ARK ETF TR ARKG ARKG 46,462 $1.4m46.5k shares
MIRATI THERAPEUTICS INC MRTX MRTX 33,100 $1.2m33.1k shares
SAREPTA THERAPEUTICS INC SRPT SRPT 8,324 $1.1m8.3k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 60,000 $1.1m60.0k shares
DELCATH SYS INC DCTH DCTH 360,569 $1.1m360.6k shares
INVENTIVA SA IVA IVA 292,599 $999.2k292.6k shares
ACHIEVE LIFE SCIENCES INC ACHV ACHV 174,714 $989.5k174.7k shares
SAGE THERAPEUTICS INC SAGE SAGE 17,805 $747.1k17.8k shares
VIKING THERAPEUTICS INC VKTX VKTX 43,156 $718.5k43.2k shares
AMYLYX PHARMACEUTICALS INC AMLX AMLX 10,000 $293.4k10.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ARGENX SE ARGX · Put ARGXPut 132,100 $51.5m132.1k shares New
BRIDGEBIO PHARMA INC BBIO · Call BBIOCall 1,229,800 $21.2m1.2m shares Added
BIOMEA FUSION INC BMEA · Call BMEACall 936,800 $20.6m936.8k shares Added
TG THERAPEUTICS INC TGTX · Call TGTXCall 826,100 $20.5m826.1k shares New
TG THERAPEUTICS INC TGTX · Put TGTXPut 826,100 $20.5m826.1k shares New
ASTRAZENECA PLC Call Call 250,000 $17.9m250.0k shares New
ARGENX SE ARGX · Call ARGXCall 38,000 $14.8m38.0k shares New
SAREPTA THERAPEUTICS INC SRPT · Put SRPTPut 122,100 $14.0m122.1k shares Reduced
VENTYX BIOSCIENCES INC VTYX · Put VTYXPut 374,100 $12.3m374.1k shares New
APELLIS PHARMACEUTICALS INC APLS · Put APLSPut 133,000 $12.1m133.0k shares New
CRISPR THERAPEUTICS AG CRSP · Put CRSPPut 200,000 $11.2m200.0k shares New
CRISPR THERAPEUTICS AG CRSP · Call CRSPCall 200,000 $11.2m200.0k shares New
REATA PHARMACEUTICALS INC RETA · Call RETACall 110,000 $11.2m110.0k shares Added
BIOMARIN PHARMACEUTICAL INC BMRN · Put BMRNPut 100,000 $8.7m100.0k shares New
ACLARIS THERAPEUTICS INC ACRS · Put ACRSPut 796,300 $8.3m796.3k shares Added
REPLIMUNE GROUP INC REPL · Put REPLPut 348,200 $8.1m348.2k shares New
IMMUNOGEN INC IMGN · Call IMGNCall 350,000 $6.6m350.0k shares Added
BIOMEA FUSION INC BMEA · Put BMEAPut 286,700 $6.3m286.7k shares Added
IMMUNOVANT INC IMVT · Call IMVTCall 326,200 $6.2m326.2k shares Added
PROTAGONIST THERAPEUTICS INC PTGX · Put PTGXPut 211,400 $5.8m211.4k shares Unchanged
PROTAGONIST THERAPEUTICS INC PTGX · Call PTGXCall 200,000 $5.5m200.0k shares Reduced
BIOHAVEN LTD BHVN · Call BHVNCall 225,000 $5.4m225.0k shares Added
REPLIMUNE GROUP INC REPL · Call REPLCall 228,300 $5.3m228.3k shares New
LEGEND BIOTECH CORP LEGN · Call LEGNCall 68,800 $4.7m68.8k shares New
INSMED INC INSM · Call INSMCall 200,000 $4.2m200.0k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15